A research team has successfully developed a next-generation coil interface capable of efficiently and safely stimulating ...

It was originally approved in 2019 for the treatment of chronic pain. The Food and Drug Administration (FDA) has approved the Proclaim™ XR spinal cord stimulation (SCS) system for the treatment of ...

Diabetic peripheral neuropathy is a debilitating, progressive neurologic disorder that affects about 30% of adults with diabetes. Spinal cord stimulation is a newer option for addressing moderate to ...

Medtronic’s neurostimulators for spinal cord stimulation help diabetic peripheral neuropathy sufferers experience significantly less pain compared to just using conventional treatments. The company’s ...

Nalu’s PNS system complements Boston’s existing neuromodulation portfolio, which includes its WaveWriter Alpha SCS system for ...

In our research and development toward applying Peripheral Electrical Stimulation (PES) using Awareness AI, we have adopted real-time gait detection using a Wearable Force Plate (see Figure 1) as the ...

At 8 months follow-up, patients with painful diabetic peripheral neuropathy who received spinal cord stimulation (SCS) implants reported improvements in pain, neuropathic and autonomic symptoms, ...

The US Food and Drug Administration has approved Abbott's Proclaim XR spinal cord stimulation (SCS) system for the treatment of patients with diabetic peripheral neuropathy (DPN), the company ...

Kristy Townsend, PhD, associate professor in the Department of Neurosurgery at The Ohio State University Wexner Medical Center and College of Medicine. Townsend's research program investigates nervous ...

Please provide your email address to receive an email when new articles are posted on . The FDA approved the use of a spinal cord stimulation therapy for the treatment of chronic pain caused by ...